Anika Therapeutics (ANIK) Change in Inventory (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Change in Inventory of $6.0 million for Q2 2026, up 447.77% year-over-year from $1.1 million in Q2 2025, and up 11.21% quarter-over-quarter from $5.4 million in Q1 2026.
Anika Therapeutics (ANIK) Change in Inventory (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Change in Inventory for 17 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Inventory rose 447.77% year-over-year to $6.0 million; the TTM figure through Jun 2026 stood at $13.6 million (up 931.83% YoY), while the FY2025 annual figure was -$30000.0, down 100.32% from the prior year.
- Change in Inventory grew to $6.0 million in Q2 2026 per ANIK's latest filing, from $5.4 million in the prior quarter.
- Across five years, Change in Inventory topped out at $6.0 million in Q2 2026 and bottomed at -$2.4 million in Q4 2024.
- Historically, Change in Inventory has averaged $2.2 million across 5 years, with a median of $2.7 million in 2022.
- Annual changes were most pronounced in 2024 — Change in Inventory plunged 176.17% — and 2026, when it jumped 1133.84%.
- Anika Therapeutics' Change in Inventory stood at $2.9 million in 2022, then grew by 6.77% to $3.1 million in 2023, then slumped by 176.17% to -$2.4 million in 2024, then soared by 174.4% to $1.8 million in 2025, then jumped by 238.0% to $6.0 million in 2026.
- Business Quant data shows ANIK's Change in Inventory at $6.0 million in Q2 2026, $5.4 million in Q1 2026, and $1.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | 6.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.01 Mn |
| Jun 30, 2026 | 6.01 Mn |
| Mar 31, 2026 | 5.41 Mn |
| Mar 31, 2026 | 5.41 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 443,000.00 |
| Sep 30, 2025 | 443,000.00 |
| Jun 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | -1.73 Mn |
| Mar 31, 2025 | -523,000.00 |
| Mar 31, 2025 | -523,000.00 |
| Dec 31, 2024 | -2.39 Mn |
| Dec 31, 2024 | -2.39 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 4.72 Mn |
| Mar 31, 2024 | 4.09 Mn |
| Mar 31, 2024 | 4.09 Mn |